USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	060651/0132			Pages:	4
		Recorded:	07/28/2022
Attorney Dkt #:	30100-10165733P 1444651 2
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 13

Patent #:	11443831	Issue Dt:	09/13/2022	Application #:	14233546	Filing Dt:	01/17/2014
Publication #:	US20140156200	Pub Dt:	06/05/2014
Title:	ASSESSMENT OF CELLULAR SIGNALING PATHWAY ACTIVITY USING PROBABILISTIC MODELING OF TARGET GENE EXPRESSION

Patent #:	11306360	Issue Dt:	04/19/2022	Application #:	14652805	Filing Dt:	06/17/2015
Publication #:	US20150347672	Pub Dt:	12/03/2015
Title:	ASSESSMENT OF CELLULAR SIGNALING PATHWAY ACTIVITY USING LINEAR COMBINATION(S) OF TARGET GENE EXPRESSIONS

Patent #:	10016159	Issue Dt:	07/10/2018	Application #:	14922561	Filing Dt:	10/26/2015
Publication #:	US20160113572	Pub Dt:	04/28/2016
Title:	DETERMINATION OF TGF-BETA PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	11261495	Issue Dt:	03/01/2022	Application #:	15023820	Filing Dt:	03/22/2016
Publication #:	US20160298196	Pub Dt:	10/13/2016
Title:	ASSESSMENT OF THE PI3K CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSION

Patent #:	11450409	Issue Dt:	09/20/2022	Application #:	15235478	Filing Dt:	08/12/2016
Publication #:	US20170046477	Pub Dt:	02/16/2017
Title:	DETERMINATION OF NFkB PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	NONE	Issue Dt:		Application #:	16002515	Filing Dt:	06/07/2018
Publication #:	US20180271438	Pub Dt:	09/27/2018
Title:	DETERMINATION OF TGF-BETA PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	NONE	Issue Dt:		Application #:	16143708	Filing Dt:	09/27/2018
Publication #:	US20190102510	Pub Dt:	04/04/2019
Title:	DETERMINATION OF JAK-STAT3 PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	11649488	Issue Dt:	05/16/2023	Application #:	16143885	Filing Dt:	09/27/2018
Publication #:	US20190100795	Pub Dt:	04/04/2019
Title:	DETERMINATION OF JAK-STAT1/2 PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	NONE	Issue Dt:		Application #:	16145263	Filing Dt:	09/28/2018
Publication #:	US20190100790	Pub Dt:	04/04/2019
Title:	DETERMINATION OF NOTCH PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	11776661	Issue Dt:	10/03/2023	Application #:	16145722	Filing Dt:	09/28/2018
Publication #:	US20190188359	Pub Dt:	06/20/2019
Title:	DETERMINATION OF MAPK-AP-1 PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

Patent #:	NONE	Issue Dt:		Application #:	17577078	Filing Dt:	01/17/2022
Publication #:	US20220259666	Pub Dt:	08/18/2022
Title:	ASSESSMENT OF THE P13K CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSION

Patent #:	NONE	Issue Dt:		Application #:	17618436	Filing Dt:	12/11/2021
Publication #:	US20230111281	Pub Dt:	04/13/2023
Title:	IDENTIFICATION OF THE CELLULAR FUNCTION OF AN ACTIVE NFKB PATHWAY

Patent #:	NONE	Issue Dt:		Application #:	17714335	Filing Dt:	04/06/2022
Publication #:	US20230030858	Pub Dt:	02/02/2023
Title:	ASSESSMENT OF CELLULAR SIGNALING PATHWAY ACTIVITY USING LINEAR COMBINATION(S) OF TARGET GENE EXPRESSIONS

Assignor

Exec Dt:

06/21/2022

Assignee

HIGH TECH CAMPUS 11

5656 AE EINDHOVEN, NETHERLANDS

Correspondence name and address
	DANIEL M. GURFINKEL
	DENNEMEYER & ASSOCIATES, LLC
	2 NORTH RIVERSIDE PLAZA, SUITE 1500
	CHICAGO, IL 60606

Search Results as of: 06/13/2024 02:15 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6